Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cephalosporins remain empiric therapy for skin infections in pediatric AD

Key clinical point: First‐generation cephalosporins are still the appropriate empiric therapy for most pediatric atopic dermatitis patients.

Major finding: Methicillin‐sensitive S. aureus (77.8%) was more prevalent than methicillin‐resistant S. aureus (22.2%) in pediatric AD patients.

Study details: A retrospective cohort study of skin cultures from 106 pediatric atopic dermatitis patients with clinically apparent bacterial skin infections.

Disclosures: The study was funded by grants from the Agency for Healthcare Research and Quality. The authors reported no conflicts of interest.

Citation:

Briscoe CC et al. Pediatr Dermatol. 2019 May 24. doi: 10.1111/pde.13867.